Home
Journal Issues
Current Issue
In Press
Archive
Guidelines
About the journal
Author Guidelines
Peer-Review Policy
Open Access and Copyright
Author Agreement Form
Create Account
Login
Please don't use dangerous characters
Title
Abstract
Full Text
Keywords
Author
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Publisher
Publication Fee
Contact Us
Archive
Indexing Information
Member of
Follower of
2025, Vol 14, No. 4
×
Journal of Renal Injury Prevention
Chief Editor: Azar Baradaran
Original
1. Vancomycin dosing in low-flux hemodialysis; is adjustment of drug dosage necessary?
Niloofar Khodabandehloo, Arash Fourodi, Aria Jenabi*
J Renal Inj Prev
. 2019;8(2): 112-115.
doi:
10.15171/jrip.2019.21
Scopus ID:
85063777039
Article
PDF
XML
Cited By:
0
0
×
Vancomycin dosing in low-flux hemodialysis; is adjustment of drug dosage necessary?
Original
2. The protective effect of lycopene supplement against vancomycin-induced nephrotoxicity; a randomized double-blind placebo-controlled clinical trial
Somayeh Haghighipour
, Rasool Soltani
, Ali Anjomshoa*
J Renal Inj Prev
. 2020;9(4): e32.
doi:
10.34172/jrip.2020.32
Scopus ID:
85089800858
Article
PDF
XML
Cited By:
2
1
×
The protective effect of lycopene supplement against vancomycin-induced nephrotoxicity; a randomized double-blind placebo-controlled clinical trial
Original
3. The frequency, risk factors, onset time, and outcome of acute kidney injury induced by vancomycin, colistin, and liposomal amphotericin B in hospitalized patients
Mojtaba Shabani-Borujeni
, Fakhrossadat Farvadi*
, Samira Sadat Abolmaali, Dena Firouzabadi, Nakisa Rasaei, Iman Karimzadeh*
J Renal Inj Prev
. 2025;14(2): e37314.
doi:
10.34172/jrip.2025.37314
Article
PDF
XML
Cited By:
0
×
The frequency, risk factors, onset time, and outcome of acute kidney injury induced by vancomycin, colistin, and liposomal amphotericin B in hospitalized patients
